Dr. Richard Fairless

Ongoing funding:

2019-2021: DFG FOR2289 “Differential susceptibility of αRGCs to glutamate excitotoxictiy in autoimmune optic neuritis”

Previous funding:

2016-2018: DFG FOR2289 “Source and influence of calcium entry in retinal ganglion cells during the preclinical phase of autoimmune optic neuritis”

2011-2013: Gemeinnützige Hertie Stiftung “Neurodegeneration during the pre-clinical phase of autoimmune optic neuritis: Role of microglia?”

2010-2012: DFG “Contribution of synaptic pathology to neurodegeneration in autoimmune optic neuritis”

2009-2011: Gemeinnützige Hertie Stiftung “Neurodegeneration during the pre-clinical phase of autoimmune optic neuritis: Role of glutamate toxicity?”